Cargando…

Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension

Pulmonary arterial hypertension (PAH), group 1 pulmonary hypertension (PH), is a fatal disease that is characterized by vasoconstriction, increased pressure in the pulmonary arteries, and right heart failure. PAH can be described by abnormal vascular remodeling, hyperproliferation in the vasculature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shihan, Mazen, Novoyatleva, Tatyana, Lehmeyer, Thilo, Sydykov, Akylbek, Schermuly, Ralph T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582672/ https://www.ncbi.nlm.nih.gov/pubmed/34769531 http://dx.doi.org/10.3390/ijerph182111009

Ejemplares similares

Genetic Delivery and Gene Therapy in Pulmonary Hypertension
por: Rai, Nabham, et al.
Publicado: (2021)

Osteopontin in Pulmonary Hypertension
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties
por: Luitel, Himal, et al.
Publicado: (2020)

Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension
por: Rai, Nabham, et al.
Publicado: (2022)

Surgical protocol for pulmonary artery banding in mice to generate a model of pressure-overload-induced right ventricular failure
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
por: Sydykov, Akylbek, et al.
Publicado: (2021)

The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary Vasculature
por: Malczyk, Monika, et al.
Publicado: (2017)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2019)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
por: Neupane, Balram, et al.
Publicado: (2020)

Clinical and Molecular Implications of Osteopontin in Heart Failure
por: Mamazhakypov, Argen, et al.
Publicado: (2022)

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
por: Veeroju, Swathi, et al.
Publicado: (2021)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021)

Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2022)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

The Roles of P2Y(2) Purinergic Receptors in Osteoblasts and Mechanotransduction
por: Xing, Yanghui, et al.
Publicado: (2014)

Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches
por: Novoyatleva, Tatyana
Publicado: (2023)

Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
por: Amirjanians, Matthieu, et al.
Publicado: (2017)

Control of Macrophage Inflammation by P2Y Purinergic Receptors
por: Klaver, Dominik, et al.
Publicado: (2021)

Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?
por: Kosanovic, Djuro, et al.
Publicado: (2017)

IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
por: Biswas, Siladitta, et al.
Publicado: (2020)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats
por: Mamazhakypov, Argen, et al.
Publicado: (2020)

Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers
por: Sydykov, Akylbek, et al.
Publicado: (2018)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018)

P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases
por: Strassheim, Derek, et al.
Publicado: (2020)

The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension
por: Viswanathan, Gayathri, et al.
Publicado: (2018)

Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2022)

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung
por: Egemnazarov, Bakytbek, et al.
Publicado: (2009)

The role of the purinergic P2X(7 )receptor in inflammation
por: Lister, Martin F, et al.
Publicado: (2007)

Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis
por: Boehm, Mario, et al.
Publicado: (2022)

Purinergic P2 Receptors: Structure and Function 2.0
por: Zemkova, Hana
Publicado: (2023)

P2 purinergic receptor modulation of cytokine production
por: Gabel, Christopher A.
Publicado: (2007)

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021)

P2 purinergic receptor dysregulation in urologic disease
por: Maynard, Janielle P., et al.
Publicado: (2022)

Using antibodies against P2Y and P2X receptors in purinergic signaling research
por: Brass, Dovrat, et al.
Publicado: (2011)

The Role of P2X7 Purinergic Receptors in the Renal Inflammation Associated with Angiotensin II-Induced Hypertension
por: Bautista-Pérez, Rocio, et al.
Publicado: (2020)

Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity
por: Weber, Felix C., et al.
Publicado: (2010)

Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response
por: Muniz, Valdirene S., et al.
Publicado: (2015)

The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
por: Alves, Mariana, et al.
Publicado: (2018)

P2Y(12) Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
por: Morrone, Fernanda Bueno, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ruvlum8a5bb6a59f2bik31i4c